- Home
- EQX vs RGC Comparison
EQX vs RGC Comparison
Compare EQX & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EQX | RGC |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | Canada | Hong Kong |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 11.5B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EQX | RGC |
|---|---|---|
| Price | $13.98 | $28.36 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 8.8M | 160.3K |
| Earning Date | 05-06-2026 | 10-31-2025 |
| Dividend Yield | ★ 0.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $102.84 | N/A |
| Revenue Next Year | $15.55 | N/A |
| P/E Ratio | $137.41 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.64 | $9.39 |
| 52 Week High | $18.96 | $950.00 |
Technical Indicators
Market Signals| Indicator | EQX | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 44.49 | 50.18 |
| Support Level | $13.54 | $21.81 |
| Resistance Level | $15.06 | $29.26 |
| Average True Range (ATR) | 0.62 | 2.15 |
| MACD | -0.02 | -0.18 |
| Stochastic Oscillator | 13.45 | 18.37 |
Price Performance
Historical ComparisonAbout EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.